Dashboard
Manage Tickers

VALN Valneva SE

Nasdaq valneva.com


$ 9.17 $ 0.00 (0 %)    

Tuesday, 04-Nov-2025 12:21:12 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 622.22 $ -1.02 (-0.16 %)
DIA $ 470.97 $ 0.61 (0.13 %)
SPY $ 676.57 $ 0.42 (0.06 %)
TLT $ 89.96 $ 0.17 (0.19 %)
GLD $ 364.38 $ 0.78 (0.21 %)
$ 9.05
$ 9.21
$ 9.04 x 2
$ 9.30 x 100
-- - --
$ 3.62 - $ 12.25
20,991
na
1.26B
$ 1.68
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

valneva-reports-phase-1-results-demonstrating-improved-immune-response-for-second-generation-zika-vaccine-candidate-vla1601
Valneva Reports Phase 1 Results Demonstrat...
11/04/2025 06:57:54

Core News & Articles
Valneva Secures Up To $500M Non-Dilutive D...
10/06/2025 15:38:55

New debt facility extends repayment from Q1 2026 to Q4 2030, lowers interest rate and provides access to additional capital for...

why-wolfspeed-shares-are-trading-higher-by-over-50-here-are-20-stocks-moving-premarket
Why Wolfspeed Shares Are Trading Higher By...
09/30/2025 09:37:13

valnevas-ixchiq-shows-95-antibody-seroresponse-sustained-four-years-after-single-dose-in-adults-aged-18-to-65
Valneva's IXCHIQ Shows 95% Antibody Serore...
09/30/2025 05:25:37

Long-lasting antibody persistence was comparable in older (65+) and younger adultsLong-term antibody persistence is a key compe...

guggenheim-maintains-buy-on-valneva-lowers-price-target-to-13
Guggenheim Maintains Buy on Valneva, Lower...
09/08/2025 13:51:23

Guggenheim analyst Vamil Divan maintains Valneva (NASDAQ:VALN) with a Buy and lowers the price target from $14 to $13.

valneva-lyme-vaccine-candidate-vla15-demonstrates-strong-anamnestic-response-and-favorable-safety-profile-after-third-yearly-booster-dose
Valneva Lyme Vaccine Candidate VLA15 Demon...
09/03/2025 06:14:03

Strong immune response after third yearly booster dose in children and adultsSignificant anamnestic antibody response across al...

canopy-growth-nvidia-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Canopy Growth, Nvidia And Other Big Stocks...
09/02/2025 12:00:00

ehang-molecular-partners-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
EHang, Molecular Partners And Other Big St...
08/26/2025 12:08:12

crude-oil-surges-2-chicago-fed-national-activity-index-edges-lower-in-july
Crude Oil Surges 2%; Chicago Fed National ...
08/25/2025 19:02:20

hc-wainwright--co-reiterates-buy-on-valneva-maintains-18-price-target
HC Wainwright & Co. Reiterates Buy on Valn...
08/25/2025 17:56:08

HC Wainwright & Co. analyst Brandon Folkes reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $18 price target.

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
08/25/2025 17:07:46

keurig-dr-pepper-valneva-venu-holding-and-other-big-stocks-moving-lower-on-monday
Keurig Dr Pepper, Valneva, Venu Holding An...
08/25/2025 16:02:33

safety-concerns-hit-valneva-as-ixchiq-chikungunya-virus-vaccine-is-suspended-in-us
Safety Concerns Hit Valneva As Ixchiq Chik...
08/25/2025 14:29:20

Valneva shares fall after FDA suspends Ixchiq vaccine license citing new safety reports, raising questions over future U.S. sal...

fda-update-on-the-safety-of-ixchiq-chikungunya-vaccine-live-fda-suspends-biologics-license-fda-safety-communication
FDA Update On The Safety Of Ixchiq (Chikun...
08/25/2025 12:55:44

https://www.fda.gov/safety/medical-product-safety-information/fda-update-safety-ixchiq-chikungunya-vaccine-live-fda-suspends-bi...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
08/25/2025 12:08:04

trading-halt-halt-status-updated-at-70000-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:00:...
08/25/2025 11:00:07

valneva-announces-fda-suspension-of-ixchiq-license-in-united-states-following-four-new-serious-adverse-events-reports
Valneva Announces FDA Suspension Of IXCHIQ...
08/25/2025 05:46:18

The suspension of the license is effective immediately and requires Valneva to stop shipping and selling of IXCHIQ® in the Unit...

trading-halt-halted-at-24812-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 2:48:12 p.m. ET - ...
08/22/2025 18:48:17

hc-wainwright--co-assumes-valneva-at-buy-announces-price-target-of-18
HC Wainwright & Co. Assumes Valneva at Buy...
08/19/2025 11:10:03

HC Wainwright & Co. analyst Brandon Folkes assumes Valneva (NASDAQ:VALN) with a Buy rating and announces Price Target of...

valnevas-single-dose-chikungunya-vaccine-ixchiq-secures-health-canada-authorization-for-individuals-aged-12-years-and-older
Valneva's Single-Dose Chikungunya Vaccine ...
08/18/2025 05:36:54

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION